Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
Abstract
Through process transfer and optimization for increased antibody production to 3 g/L for a GS‐CHO cell line, an undesirable drop in antibody Fc galactosylation was observed. Uridine (U), manganese chloride (M), and galactose (G), constituents involved in the intracellular galactosylation process, were evaluated in 2‐L bioreactors for their potential to specifically increase antibody galactosylation. These components were placed in the feed medium at proportionally increasing concentrations from 0 to 20× UMG, where a 1× concentration of U was 1 mM, a 1× concentration of M was 0.002 mM, and a 1× concentration of G was 5 mM. Antibody galactosylation increased rapidly from 3% at 0× UMG up to 21% at 8× UMG and then more slowly to 23% at 20× UMG. The increase was primarily due to a shift from G0F to G1F, with minimal impact on other glycoforms or product quality attributes. Cell culture performance was largely not impacted by addition of up to 20× UMG except for suppression of glucose consumption and lactate production at 16 and 20× UMG and a slight drop in antibody concentration at 20× UMG. Higher accumulation of free galactose in the medium was observed at 8× UMG and above, coincident with achieving the plateau of maximal galactosylation. A concentration of 4× UMG resulted in achieving the target of 18% galactosylation at 2‐L scale, a result that was reproduced in a 1,000‐L run. Follow‐up studies to evaluate the addition of each component individually up to 12× concentration revealed that the effect was synergistic; the combination of all three components gave a higher level of galactosylation than addition of the each effect independently. The approach was found generally useful since a second cell line responded similarly, with an increase in galactosylation from 5% to 29% from 0 to 8× UMG and no further increase or impact on culture performance up to 12× UMG. These results demonstrate a useful approach to provide exact and specific control of antibody galactosylation through manipulation of the concentrations of uridine, manganese chloride, and galactose in the cell culture medium. Biotechnol. Bioeng. 2011; 108:1591–1602. © 2011 Wiley Periodicals, Inc.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Under galactose supplementation, reduced glucose uptake leads to elevated extracellular glucose concentrations and altered intracellular precursor dynamics.
“Under galactose supplementation, reduced glucose uptake leads to elevated extracellular glucose concentrations and altered intracellular precursor dynamics [47].”
From Soft sensing of intracellular states for CHO cell bioprocessing with Ensemble Kalman Filters (2026) · cites this paper as [47]
When galactose is supplemented, carbon flux can be redirected towards central energy metabolism, reducing reliance on glucose as the primary carbon and energy source.
“When galactose is supplemented, carbon flux can be redirected towards central energy metabolism, reducing reliance on glucose as the primary carbon and energy source.”
From Soft sensing of intracellular states for CHO cell bioprocessing with Ensemble Kalman Filters (2026) · cites this paper as [47]
Cites
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · see citing works
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413 · see citing works
Glycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829 · cited 4× · see citing works
“Fortunately, antibody Fc glycosylation is relatively restricted and is typically comprised of low levels of high mannose structures with the vast majority of forms as complex, corefucosylated, biantennary structures with variable levels of terminal galactosylation and minimal sialylation (Jefferis, 2009).”
BackgroundInfluential
Flagged first, then by citations
Cited by
Sorted by citations
Antibody glycoengineering strategies in mammalian cells
Wang, Q., Chung, C., Chough, S., & Betenbaugh, M. J. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26567 · Cited by 94 · see citing works
Park, J. H., Noh, S. M., Woo, J. R., Kim, J. W., & Lee, G. M. (2016) · Biotechnology Journal · doi:10.1002/biot.201500327 · Cited by 81 · see citing works
Madabhushi, S. R., Podtelezhnikov, A. A., Murgolo, N., Xu, S., & Lin, H. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.01.023 · Cited by 27 · see citing works
Bravo-Venegas, J., Rodriguez-Siza, J., Vergara, M., Torres, M., Dickson, A., Toledo, J. R., Molina, M. C., Hermoso, M. A., Berríos, J., & Altamirano, C. (2026) · mAbs · doi:10.1080/19420862.2026.2643039 · Cited by 3 · see citing works
“41,66 Blondeel & Aucoin 26 systematically reviewed the impact of culture media supplementation on glycosylation using the GIx approach; the reported supplementation strategies with significant ΔGIx serve as a positive control to the results presented in our work.”
Soft sensing of intracellular states for CHO cell bioprocessing with Ensemble Kalman Filters
Yu, L., del Rio Chanona, A., & Kontoravdi, C. (2026) · Journal of Process Control · doi:10.1016/j.jprocont.2026.103875
- Authors
- Gramer, M. J., Eckblad, J. J., Donahue, R., Brown, J., Shultz, C., Vickerman, K., Priem, P., van den Bremer, E. T. J., Gerritsen, J., & van Berkel, P. H. C.
- Affiliations
- Genmab (United States) (US)
- Genmab (Netherlands) (NL)
- Corresponding author
- Gramer, Michael J.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2011-02-18
- Volume
- 108
- Issue
- 7
- Pages
- 1591-1602
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2162406947
- Cited by
- 193
- References
- 3
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 7 · 2023: 8 · 2022: 10 · 2021: 15 · 2020: 20 · 2019: 14 · 2018: 20 · 2017: 15 · 2016: 17 · 2015: 13 · 2014: 15 · 2013: 10 · 2012: 3
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology and Bioengineering (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- Fc glycosylation, uridine supplementation, manganese chloride, galactose supplementation, CHO cell culture, glucose utilization, lactic acid production, monoclonal antibody production, bioreactor scale-up
- MeSH terms
- Animals, Antibodies, Chlorides, Cricetulus, Culture Media, Galactose, Glycosylation, Cricetinae, Recombinant Proteins, Uridine, CHO Cells, Manganese Compounds, Bioreactors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review